BARCLAYS PLC UK Regulatory Announcement: Form 8.3 – UDG HEALTHCARE PLC
LONDON–(BUSINESS WIRE)–
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | UDG HEALTHCARE PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 19 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,894,973 | 1.55% | 237,352 | 0.09% | ||
(2) | Derivatives (other than options): | ||||
174,066 | 0.07% | 3,372,869 | 1.34% | ||
(3) | Options and agreements to | ||||
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
TOTAL: | |||||
4,069,039 | 1.62% | 3,610,221 | 1.43% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 281 | 10.2411 GBP |
Purchase | 362 | 10.2400 GBP |
Purchase | 1,669 | 10.2200 GBP |
Purchase | 1,822 | 10.2364 GBP |
Purchase | 3,109 | 10.2341 GBP |
Purchase | 4,768 | 10.2600 GBP |
Purchase | 6,622 | 10.2594 GBP |
Purchase | 9,903 | 10.2572 GBP |
Purchase | 10,474 | 10.2500 GBP |
Purchase | 14,510 | 10.2305 GBP |
Purchase | 16,861 | 10.2383 GBP |
Purchase | 21,909 | 10.2300 GBP |
Purchase | 26,919 | 10.2296 GBP |
Sale | 558 | 10.2348 GBP |
Sale | 831 | 10.2347 GBP |
Sale | 844 | 10.2353 GBP |
Sale | 1,038 | 10.2200 GBP |
Sale | 1,382 | 10.2451 GBP |
Sale | 1,467 | 10.2217 GBP |
Sale | 1,736 | 10.2400 GBP |
Sale | 2,088 | 10.2482 GBP |
Sale | 4,169 | 10.2303 GBP |
Sale | 5,092 | 10.2281 GBP |
Sale | 6,499 | 10.2605 GBP |
Sale | 10,005 | 10.2578 GBP |
Sale | 20,075 | 10.2394 GBP |
Sale | 33,000 | 10.2198 GBP |
Sale | 54,258 | 10.2300 GBP |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
unit | |||
SWAP | Long | 3 | 10.2600 GBP |
CFD | Long | 145 | 10.2488 GBP |
CFD | Long | 1,943 | 10.2489 GBP |
SWAP | Long | 2,484 | 10.2379 GBP |
SWAP | Long | 4,193 | 10.2303 GBP |
SWAP | Long | 6,206 | 10.2212 GBP |
SWAP | Long | 6,799 | 10.2300 GBP |
SWAP | Long | 33,000 | 10.2198 GBP |
CFD | Short | 281 | 10.2411 GBP |
SWAP | Short | 2,927 | 10.2570 GBP |
CFD | Short | 3,655 | 10.2371 GBP |
SWAP | Short | 7,574 | 10.2335 GBP |
SWAP | Short | 11,483 | 10.2323 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure | 20 May 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection (Note 10) |
|
Contacts
BARCLAYS PLC